资金涌入！这些绩优基金规模大增，热门板块最新研判出炉

Core Viewpoint - The article highlights the significant inflow of funds into high-performing funds in the technology and pharmaceutical sectors during the third quarter, indicating a bullish market sentiment and investment opportunities in these areas [3][4]. Fund Performance - Multiple fund companies, including China Europe Fund and Yongying Fund, have reported substantial growth in their fund sizes for the third quarter, particularly in technology and pharmaceutical sectors [3]. - The China Europe Digital Economy Mixed Fund, managed by Feng Ludan, saw its size increase from 1.527 billion to 13.022 billion, a growth of over 750%, with a year-to-date return exceeding 127% [5]. - Yongying Technology Select Fund's size expanded from 1.166 billion to 11.521 billion, achieving a year-to-date return of over 185% [5]. - The Long城 Pharmaceutical Industry Select Fund increased its size from 1.132 billion to 1.790 billion, with a year-to-date return exceeding 80% [6]. Investment Trends - The article notes a significant increase in holdings of key stocks in the technology sector, such as Xin Yiseng and Alibaba, by the Yongying Technology Select Fund [5]. - In the pharmaceutical sector, the Long城 Pharmaceutical Industry Select Fund's top holdings include companies like Innovent Biologics and 3SBio, focusing on clinical data and overseas licensing [6]. AI Sector Insights - The AI sector is experiencing both investment opportunities and risks, with high valuations leading to increased scrutiny on performance [8][9]. - The global cloud computing industry remains a focal point for investment, with AI model values being optimized through various strategies [9][10]. - The article suggests that investors should diversify their investments in the AI sector to mitigate risks associated with high valuations and market volatility [9]. Future Outlook - The Long城 Pharmaceutical Industry Select Fund manager emphasizes a shift towards focusing on core pipeline competitiveness and the balance between long-term growth potential and market expectations [10].